BFA
TPST icon

BlackRock Fund Advisors’s Tempest Therapeutics TPST Stock Holding History

BlackRock Fund Advisors’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.57M Sell
352
-109
-24% -$1.36M ﹤0.01% 3193
2016
Q3 		$9.66M Buy
461
+32
+7% +$579K ﹤0.01% 2491
2016
Q2 		$6.54M Buy
429
+98
+30% +$2.24M ﹤0.01% 2650
2016
Q1 		$9.18M Buy
331
+4
+1% +$84.5K ﹤0.01% 2406
2015
Q4 		$9.35M Buy
327
+115
+54% +$3.79M ﹤0.01% 2487
2015
Q3 		$5.27M Buy
212
+1
+0.5% +$67.3K ﹤0.01% 2775
2015
Q2 		$17.9M Buy
211
+52
+33% +$4.76M ﹤0.01% 2184
2015
Q1 		$16.2M Buy
159
+15
+10% +$2M ﹤0.01% 2178
2014
Q4 		$18.6M Buy
144
+22
+18% +$1.61M ﹤0.01% 2106
2014
Q3 		$5.94M Sell
122
-8
-6% -$280K ﹤0.01% 2648
2014
Q2 		$3.48M Buy
130
+16
+14% +$377K ﹤0.01% 3022
2014
Q1 		$2.97M Buy
114
+31
+37% +$879K ﹤0.01% 3065
2013
Q4 		$2.23M Sell
83
-4
-5% -$110K ﹤0.01% 3127
2013
Q3 		$2.52M Buy
87
+10
+13% +$355K ﹤0.01% 3085
2013
Q2 		$3.09M Buy
+77
New +$2.89M ﹤0.01% 2974

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

BlackRock Fund Advisors's TPST Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Tempest Therapeutics (TPST) stake by 24% in Q4 2016, selling an estimated $1.36M and leaving 352 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

BlackRock Fund Advisors first reported a position in TPST in Q2 2013 and has held it in 15 quarters since. The position peaked at $18.6M in Q4 2014. 84 funds tracked by Wall St. Rank hold TPST as of Q4 2016.

  • BlackRock Fund Advisors held 352 shares of Tempest Therapeutics worth $1.57M as of Q4 2016.
  • BlackRock Fund Advisors sold 109 Tempest Therapeutics shares in Q4 2016, an estimated $1.36M.
  • Tempest Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3193 holding.
  • BlackRock Fund Advisors first reported a position in Tempest Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Tempest Therapeutics position peaked at $18.6M in Q4 2014.
  • 84 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.